Dr Ravi completed the entirety of his medical specialization in the United States — a milestone achieved by very few ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...